| 1 | 31546603 | Xanthine Oxidase Inhibitor Febuxostat Exerts an Anti-Inflammatory Action and Protects against Diabetic Nephropathy Development in KK-Ay Obese Diabetic Mice. | Int J Mol Sci | 2019 Sep 21 |
6 |
| 2 | 31556223 | The effects of topiroxostat on vascular function in patients with hyperuricemia. | J Clin Hypertens (Greenwich) | 2019 Nov |
1 |
| 3 | 31560952 | Inhibition of xanthine oxidoreductase protects against contrast-induced renal tubular injury by activating adenosine monophosphate-activated protein kinase. | Free Radic Biol Med | 2019 Dec |
4 |
| 4 | 31677062 | Febuxostat, a novel inhibitor of xanthine oxidase, reduces ER stress through upregulation of SIRT1-AMPK-HO-1/thioredoxin expression. | Clin Exp Nephrol | 2020 Mar |
7 |
| 5 | 31748427 | Changeover Trial of Febuxostat and Topiroxostat for Hyperuricemia with Cardiovascular Disease: Sub-Analysis for Chronic Kidney Disease (TROFEO CKD Trial). | Ann Thorac Cardiovasc Surg | 2020 Aug 20 |
1 |
| 6 | 31754153 | Febuxostat, a Xanthine Oxidoreductase Inhibitor, Decreases NLRP3-dependent Inflammation in Macrophages by Activating the Purine Salvage Pathway and Restoring Cellular Bioenergetics. | Sci Rep | 2019 Nov 21 |
3 |
| 7 | 31882426 | Urate Transporter URAT1 in Hyperuricemia: New Insights from Hyperuricemic Models. | Ann Clin Lab Sci | 2019 Nov |
1 |
| 8 | 31965018 | Xanthine oxidase inhibition attenuates insulin resistance and diet-induced steatohepatitis in mice. | Sci Rep | 2020 Jan 21 |
2 |
| 9 | 31972252 | Supplementation of dietary nitrate attenuated oxidative stress and endothelial dysfunction in diabetic vasculature through inhibition of NADPH oxidase. | Nitric Oxide | 2020 Mar 1 |
1 |
| 10 | 32054342 | Protective effect of febuxostat in sepsis-induced liver and kidney injuries after cecal ligation and puncture with the impact of xanthine oxidase, interleukin 1<i>β</i>, and c-Jun N-terminal kinases. | Hum Exp Toxicol | 2020 Jul |
1 |